I think I heard 400 paid patients on Iclusig through April, not in the PR. 1300 likely by year end. That's recurring $130M for that group. $230 likely next year. 2013 Revenues will exceed $80M, could see $90M or more.
As these revenues build, dilution via capital raising diminish.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.